Tandem Diabetes Care Inc
Statements
Cash Flow
Tandem Diabetes Care Inc (TNDM) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -35 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -18 | -14 | -21 | -15 | -19 | -12 | -12 | -6.7 | -3.5 | 14 | -4.1 | 3.6 | 23 | 19 | -21 | 15 | 15 | 15 | 29 | 29 | 34 | 20 | 14 | 6.9 | 24 | 5.8 | -18 | -6.3 | 0.1 | -7.2 | -8.0 | -5.3 | 27 | 11 | -18 | -9.5 | 8.3 | 9.8 | 11 | -35 | -5.5 | |
| 1.3 | 1.5 | 1.4 | 1.6 | 1.7 | 2.1 | 1.5 | 1.4 | 1.5 | 1.5 | 1.4 | 1.5 | 1.5 | 1.6 | 1.8 | 2.2 | 3.0 | 7.3 | 3.5 | 3.4 | 3.4 | 3.5 | 3.6 | 3.6 | 3.5 | 3.6 | 3.4 | 4.3 | 4.0 | 4.0 | 4.0 | 4.5 | 4.2 | 4.2 | 4.3 | 4.4 | 4.5 | 4.5 | 3.8 | 5.2 | 18 | |
| 2.9 | 2.9 | 3.0 | 5.1 | 2.4 | 2.1 | 1.2 | 2.7 | 9.5 | 10 | 9.8 | 12 | 17 | 19 | 16 | 16 | 13 | 13 | 13 | 15 | 16 | 17 | 18 | 20 | 22 | 24 | 21 | 23 | 21 | 23 | 22 | 25 | 26 | 28 | 25 | 26 | 21 | 20 | 16 | 16 | 73 | |
| 5.1 | 4.6 | 3.9 | 5.8 | 3.1 | 1.5 | 16 | 46 | 28 | 8.4 | 24 | 14 | 16 | 20 | 18 | 30 | 17 | 11 | 14 | 16 | 17 | 19 | 20 | 21 | 54 | 27 | 101 | -40 | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 5.3 | -4.9 | -2.6 | -0.8 | -8.3 | -4.4 | 2.1 | 4.6 | 0.9 | 0.8 | -6.1 | -9.9 | 8.5 | -4.8 | -26 | 9.4 | 0.4 | -23 | 16 | 5.4 | 7.5 | -14 | 4.2 | -4.6 | 14 | -18 | -0.1 | -15 | 6.0 | -8.3 | 4.9 | -11 | 15 | -23 | -5.8 | 9.2 | -2.9 | -24 | 3.7 | -41 | -64 | |
| 2.1 | 2.7 | 2.6 | 1.4 | 0.2 | 1.4 | 0.5 | 0.6 | 1.0 | 0.9 | 1.4 | 6.8 | 4.6 | 6.7 | 6.8 | 15 | 6.8 | 4.1 | 3.5 | 11 | 3.1 | 5.7 | 2.6 | 12 | 14 | 5.6 | 11 | 7.9 | 5.4 | 27 | 4.5 | 6.5 | 5.2 | 3.1 | 3.0 | 6.2 | 4.1 | 6.7 | 6.3 | 4.1 | 21 | |
| 5.8 | 4.6 | 2.6 | 1.8 | -0.2 | -1.4 | -9.5 | -28 | -47 | -6.6 | 0.8 | -15 | -22 | -21 | 33 | -132 | -138 | -60 | -6.1 | -65 | -39 | -77 | 5.2 | 6.4 | -14 | 36 | -26 | 5.7 | -49 | -17 | -5.1 | -3.5 | -20 | 5.0 | 9.2 | 58 | 21 | -15 | -195 | -87 | -277 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 0.0 | 0.7 | 0.3 | -0.2 | 0.6 | 0.6 | 6.5 | 23 | 0.8 | 2.0 | 2.0 | 8.8 | 7.0 | 6.4 | 11 | 19 | 30 | 9.2 | 3.6 | 14 | 19 | 16 | 3.5 | 8.3 | -0.4 | 6.1 | -0.5 | 3.4 | -1.8 | 1.8 | -30 | -3.0 | 3.0 | – | – | – | – | – | – | – | – | |
| – | 35 | -8.0 | -8.0 | – | -88 | -88 | -88 | -88 | -88 | – | – | 288 | 288 | 288 | 279 | -8.8 | -8.8 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.0 | 0.0 | 0.0 | -41 | 0.0 | 0.0 | 291 | 0.0 | 291 | |
| 0.0 | 36 | 14 | -0.2 | 4.0 | 15 | 71 | 23 | 22 | 2.0 | 2.0 | 8.8 | 7.0 | 6.4 | 11 | 264 | 30 | 9.2 | 3.6 | 14 | 19 | 16 | 3.5 | 8.1 | -0.8 | 6.1 | -0.5 | 3.9 | -1.9 | 2.6 | 14 | -3.0 | -4.5 | 2.3 | -4.7 | -40 | -1.6 | 2.6 | 274 | 2.2 | 277 | |
| -12 | 27 | -4.3 | -13 | -15 | 1.6 | 49 | -12 | -28 | 9.5 | -1.4 | -2.3 | 7.9 | 5.1 | 23 | 148 | -93 | -35 | 26 | -22 | 14 | -41 | 23 | 21 | 8.8 | 49 | -45 | 3.0 | -51 | -21 | 0.1 | -11 | 1.3 | 20 | -16 | 11 | 28 | -1.3 | 89 | -117 | -1.3 | |
| -20 | -16 | -23 | -16 | -19 | -13 | -13 | -7.3 | -4.5 | 13 | -5.5 | -3.2 | 18 | 13 | -27 | 0.9 | 7.7 | 11 | 25 | 18 | 31 | 14 | 11 | -5.2 | 10 | 0.2 | -29 | -14 | -5.3 | -35 | -12 | -12 | 22 | 7.6 | -21 | -16 | 4.2 | 3.1 | 4.8 | -39 | -27 |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.